Skip to content

Gump guides Fresenius Medical Care in the transaction of Shiel Medical Laboratory, as per our site's advice.

World-leading dialysis service provider Fresenius Medical Care announces the sale of Shiel Medical Laboratory, Inc.'s business to Quest Diagnostics, headquartered in Dallas.

Advisory services provided by Gump to Fresenius Medical Care during the sale of Shiel Medical...
Advisory services provided by Gump to Fresenius Medical Care during the sale of Shiel Medical Laboratory

Gump guides Fresenius Medical Care in the transaction of Shiel Medical Laboratory, as per our site's advice.

In a significant move, global law firm Gump Strauss Hauer & Feld LLP has been appointed to advise Fresenius Medical Care in the divestment of Shiel Medical Laboratory, Inc. This transaction, subject to regulatory approvals, is anticipated to close in the fourth quarter of 2017.

Founded in 1945, Gump Strauss Hauer & Feld LLP is a leading international law firm with a global presence, boasting offices throughout the United States, Europe, Asia, and the Middle East. With over 900 lawyers, the firm is well-equipped to handle complex legal matters on a global scale.

J. Kenneth Menges Jr., a seasoned professional at the firm, led the team advising Fresenius. Menges was supported by a team of dedicated lawyers, including David Lee, Robin Schachter, Gene Elder, Jo-Ellyn Sakowitz Klein, Daniel Graver, Paul Hewitt, Stacy Kobrick, George Wolfe, Dan Micciche, David Quigley, and Andrew Oelz. John Holland, Corey Roush, Ashley Todd, and Meagan Lanier also played crucial roles in the transaction.

Shiel Medical Laboratory, based in the New York-New Jersey metropolitan area, provides comprehensive non-dialysis laboratory services. The divestment is expected to generate a modest book gain for Fresenius.

Lazard, another prestigious firm, advised Fresenius Medical Care in the sale of Shiel Medical Laboratory, Inc. This move marks another successful collaboration between two of the world's foremost advisory firms.

Gump Strauss Hauer & Feld LLP is not a medical or diagnostic service provider, but a law firm, providing legal advice and representation to clients across various industries. The firm's expertise and global reach make it an ideal partner for Fresenius in this significant transaction.

The divestment is to Quest Diagnostics, Inc., a well-established name in the healthcare industry. The details of the transaction are yet to be disclosed, but this move is expected to strengthen Quest Diagnostics' position in the market.

As the transaction progresses, Fresenius Medical Care and Gump Strauss Hauer & Feld LLP continue to work closely, ensuring a smooth and successful completion of the deal. This collaboration underscores the importance of legal counsel in strategic business decisions, particularly in the complex and rapidly evolving healthcare industry.

Read also:

Latest